发明名称 |
Anticorpo humanizado a9-integrina anti-humana, polinucleotideo, vetor de expressão, célula hospedeira, método para produzir um anticorpo a9-integrina anti-humana, fármaro terapêutico para artrite reumatóide, método para prevenir ou tratar artrite reumatóide e uso do anticorpo humanizado a9-integrina anti-humana |
摘要 |
<p>The present invention provides a humanized anti-human ±9 integrin antibody having improved activity and/or property as compared to donor mouse anti-human ±9 integrin antibody, namely, a humanized anti-human ±9 integrin antibody comprising a heavy-chain variable region consisting of the amino acid sequence shown by SEQ ID NO: 1 or the amino acid sequence shown by SEQ ID NO: 1 wherein one or several amino acids are substituted, deleted, inserted and/or added and a light-chain variable region consisting of the amino acid sequence shown by SEQ ID NO: 61 or the amino acid sequence shown by SEQ ID NO: 61 wherein one or several amino acids are substituted, deleted, inserted and/or added, as well as a means for preventing or treating various diseases involving human ±9 integrin in their pathogenesis, which uses the antibody.</p> |
申请公布号 |
BRPI0905656(A2) |
申请公布日期 |
2015.07.07 |
申请号 |
BR2009PI05656 |
申请日期 |
2009.01.09 |
申请人 |
ASTELLAS PHARMA INC. |
发明人 |
KENJI UEHARA;HIROFUMI HIGUCHI;TOSHIHIRO NAKASHIMA;DAISUKE ISHIKAWA;NOBUCHIKA YAMAMOTO;HIDROTADA FUJITA;FUMIHIKO SAKAI |
分类号 |
C12N15/00;A61K39/395;A61P29/00;C07K16/28;C07K16/46;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/09;C12P21/08 |
主分类号 |
C12N15/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|